DOI:
10.1055/s-00023610
Drug Research
LinksClose Window
References
Bolinder J, Ljunggren Ö, Johansson L. et al.
Dapagliflozin maintains glycaemic control while reducing weight and body fat mass over 2 years in patients with type 2 diabetes mellitus inadequately controlled on metformin.
Diabetes Obes Metab 2014;
16: 159-169
Access:
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.